Hemophilia

• FDA approval · 2007-05-23
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Desmopressin Acetate submitted by Apotex Corp. under an ANDA.

• CLINICAL_TRIALS trial_result · 2007-04-20
  Clinical Trial Update: Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation [Phase 3]

  A Phase 3 clinical trial evaluating NovoSeven (recombinant Factor VIIa) for restoring coagulation activation in Hemophilia A has completed.

• CLINICAL_TRIALS trial_result · 2007-04-19
  Clinical Trial Update: The FEIBA NovoSeven Comparative Study [NA]

  A completed clinical trial comparing FEIBA versus NovoSeven in patients with severe Hemophilia A with inhibitors.

• CLINICAL_TRIALS trial_result · 2007-04-04
  Clinical Trial Update: Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B [Phase 1, Phase 2]

  This clinical trial update discusses a Phase 1/2 gene transfer therapy being studied for severe Hemophilia B. The study status is terminated…

• FDA approval · 2006-12-03
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA granted a supplemental approval for Desmopressin Acetate from Apotex Corp. under an ANDA, authorizing its generic product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS other · 2006-11-30
  Clinical Trial Update: Musculoskeletal Function in Hemophilia

  Clinical Trial Update on Musculoskeletal Function in Hemophilia, sponsored by Christian Medical College, Vellore, India; the trial status is…

• CLINICAL_TRIALS trial_result · 2006-11-16
  Clinical Trial Update: Clot Formation and Clot Stability in Patients With Severe Haemophilia A [NA]

  This completed clinical trial examined clot formation and clot stability in patients with severe Hemophilia A.